Merus N.V.
MRUS
Equity
ISIN NL0011606264 / Valor 32548496
NASDAQ (2026-01-14)
USD 90.00%
Merus N.V.
UMushroom community rating:
About company
Merus N.V. is a clinical-stage oncology company focused on developing innovative, full-length multispecific antibodies for cancer treatment.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
131%1Y
483%3Y
293%5Y
Performance
62.2%1Y
56.5%3Y
62.8%5Y
Volatility
6826 M
Market cap (USD)
Daily traded volume (Shares)
42.2 / 41.4
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
